Seki H
Nihon Sanka Fujinka Gakkai Zasshi. 1986 Mar;38(3):317-26.
The purpose of this study is to know and compare the changes in plasma proteins in normal pregnancy with those in gynecological malignancies. The results obtained are as follows. Factor VIII activity continued to increase during pregnancy and reached about 200%. It also continued to increase and showed a high level (250-300%) in malignancy, in advanced stages. At III activity increased in the first trimester and showed reached a normal level after 28 weeks of gestation. It decreased on the third day of puerperium and recovered to normal 1 month after delivery. At III activity decreased only in the end stage of malignancy. Factor XIII activity continued to decrease and was 50-60% during the second and third trimester. It began to recover at the third day of puerperium and completely recovered at 1 month after delivery. Factor XIII activity also continued to decrease and was at a low level (33.8-51%) in advanced stages. Plasminogen activity increased from the first trimester and was 120-130% during the second and third trimesters and after delivery. In malignancy, it did not show any remarkable change. alpha 2-PI activity moderately increased in the first trimester, but was at a normal level during the second and the third trimester. It increased slightly on the third day of the puerperium and recovered to normal 1 month after delivery. alpha 2-PI activity showed no remarkable change in malignancy, but decreased in some advanced cases. HRG began to decrease from the second trimester and was 46.5% at the end of the third trimester. In the puerperium, HRG began to recover on the third day and reached normal at 1 month. HRG showed a low titer in advanced stages of malignancy. Sialic acid increased constantly during pregnancy, but it was within the normal range. On the third day of puerperium, it reached 72.3mg/dl. Sialic acid showed a high level with in advanced stages of malignancy. IAP did not change during pregnancy. It showed a slight increase on the third day after delivery, but it was within the normal range. Malignancy showed a high level of HRG with in advanced stages. CIG was normal during and after pregnancy. In cervical carcinoma, CIG increased at in Ib, II and cervical carcinoma. Ovarian carcinoma did not show any change.
本研究的目的是了解并比较正常妊娠与妇科恶性肿瘤患者血浆蛋白的变化情况。所得结果如下。因子VIII活性在孕期持续升高,可达约200%。在恶性肿瘤晚期也持续升高并处于高水平(250 - 300%)。III因子活性在孕早期升高,妊娠28周后达到正常水平。产后第三天降低,产后1个月恢复正常。III因子活性仅在恶性肿瘤末期降低。因子XIII活性在妊娠中期和晚期持续下降,降至50 - 60%。产后第三天开始恢复,产后1个月完全恢复。因子XIII活性在晚期也持续下降并处于低水平(33.8 - 51%)。纤溶酶原活性从孕早期开始升高,在妊娠中期、晚期及产后为120 - 130%。在恶性肿瘤中,未显示出任何显著变化。α2 - PI活性在孕早期适度升高,但在妊娠中期和晚期处于正常水平。产后第三天略有升高,产后1个月恢复正常。α2 - PI活性在恶性肿瘤中无显著变化,但在一些晚期病例中降低。HRG从妊娠中期开始下降,妊娠晚期末为46.5%。在产褥期,HRG在产后第三天开始恢复,1个月时达到正常。HRG在恶性肿瘤晚期滴度较低。唾液酸在孕期持续升高,但在正常范围内。产后第三天达到72.3mg/dl。唾液酸在恶性肿瘤晚期处于高水平。IAP在孕期无变化。产后第三天略有升高,但在正常范围内。恶性肿瘤在晚期HRG水平较高。CIG在孕期及产后正常。在Ib期、II期宫颈癌中CIG升高,卵巢癌未显示任何变化。